Sharps Technology (STSS) Liabilities and Shareholders Equity (2021 - 2025)
Sharps Technology recorded quarterly Liabilities and Shareholders Equity of $269.1 million in Q4 2025, down 39.39% quarter-over-quarter from $444.0 million in Q3 2025, and up 3579.03% year-over-year from $7.3 million in Q4 2024.
Sharps Technology's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $269.1 million for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity rose 3579.03% year-over-year to $269.1 million; the TTM figure through Dec 2025 stood at $730.1 million (up 1806.14% YoY), while the FY2025 annual figure was $269.1 million, up 3579.03% from the prior year.
- Liabilities and Shareholders Equity came in at $269.1 million for Q4 2025 at Sharps Technology, down from $444.0 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $444.0 million in Q3 2025 to a low of $4.9 million in Q1 2022.
- A 5-year average of $54.4 million and a median of $11.8 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 37.96% in 2024 and jumped 3844.94% in 2025, its largest moves.
- Sharps Technology's Liabilities and Shareholders Equity stood at $5.9 million in 2021, then soared by 100.59% to $11.8 million in 2022, then dropped by 0.43% to $11.8 million in 2023, then sank by 37.96% to $7.3 million in 2024, then jumped by 3579.03% to $269.1 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $269.1 million, $444.0 million, and $17.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 8.78 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 4.11 Bn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 14.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 12.42 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 6.31 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 19.85 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 5.10 Bn |
| 10 | Sharps Technology | 203.95 Mn | -56.54 Mn | 1.79 Mn | 269.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 269.08 Mn |
| Sep 30, 2025 | 443.96 Mn |
| Jun 30, 2025 | 17.09 Mn |
| Dec 31, 2024 | 7.31 Mn |
| Sep 30, 2024 | 11.25 Mn |
| Jun 30, 2024 | 9.93 Mn |
| Mar 31, 2024 | 9.80 Mn |
| Dec 31, 2023 | 11.79 Mn |
| Sep 30, 2023 | 14.37 Mn |
| Jun 30, 2023 | 11.79 Mn |
| Mar 31, 2023 | 13.53 Mn |
| Dec 31, 2022 | 11.84 Mn |
| Sep 30, 2022 | 13.53 Mn |
| Jun 30, 2022 | 15.03 Mn |
| Mar 31, 2022 | 4.94 Mn |
| Dec 31, 2021 | 5.90 Mn |